Page last updated: 2024-09-05

erlotinib hydrochloride and garcinol

erlotinib hydrochloride has been researched along with garcinol in 1 studies

Compound Research Comparison

Studies (erlotinib hydrochloride)	Trials (erlotinib hydrochloride)	Recent Studies (post-2010) (erlotinib hydrochloride)	Studies (garcinol)	Trials (garcinol)	Recent Studies (post-2010) (garcinol)
4,353	786	3,033	153	2	118

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afaq, S; Ahmad, A; Biersack, B; Faisal, M; Farhan, M; Farooqi, AA; Malik, A; Schobert, R; Ullah, MF	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and garcinol

Article	Year
Garcinol Sensitizes NSCLC Cells to Standard Therapies by Regulating EMT-Modulating miRNAs. International journal of molecular sciences, 2019, Feb-13, Volume: 20, Issue:4 Topics: Apoptosis; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Lung Neoplasms; MicroRNAs; Terpenes; Transforming Growth Factor beta1	2019

Article

Year

Garcinol Sensitizes NSCLC Cells to Standard Therapies by Regulating EMT-Modulating miRNAs.

International journal of molecular sciences, 2019, Feb-13, Volume: 20, Issue:4

Topics: Apoptosis; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Lung Neoplasms; MicroRNAs; Terpenes; Transforming Growth Factor beta1

2019